Stephan Wenninger
12PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 14, 2026
First multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease.Daniel H Mendelsohn, Angela Rosenbohm, Anne-Katrin Güttsches
|Sep 11, 2025
Efficacy and safety of respiratory strength and endurance training in patients with myotonic dystrophy type 1 (DM1): a randomized controlled trial.Stephan Wenninger, Eva Heidsieck, Corinna Wirner-Piotrowski
|Sep 11, 2025
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions.Daniel H Mendelsohn, Natalia Garcia-Angarita, Andreas Hahn
|Dec 20, 2024
Updated Structure of <i>CNBP</i> Repeat Expansions in Patients With Myotonic Dystrophy Type 2 and Its Implication for Standard Diagnostics.Martin Wendlandt, Hannes Erdmann, Simone Rost
|Aug 29, 2024
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.Harmke A van Kooten, Mike C Horton, Stephan Wenninger
|Jun 14, 2024
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield
Pageof 2
Frequent Collaborators
8 joint publications
Benedikt Schoser
2 joint publications
Sarah A Cumming
2 joint publications
Cecilia Jimenez-Moreno
2 joint publications
Ans T van der Ploeg
2 joint publications
Pieter A van Doorn
2 joint publications
Darren G Monckton
2 joint publications
Kristina Gutschmidt
2 joint publications
Nadine A M E van der Beek
1 joint publications
Kees Okkersen
1 joint publications
Gráinne Gorman
